More importantly, we evaluated the translational implications of this discovery by screening a high‐affinity antibody designed to selectively disrupt the interaction between B7‐H3 and c‐Met, demonstrating strong anti‐tumor activities, surpassing that of the B7‐H3‐specific antibody lacking the blocking capability. This evidence concerns the gene MET and neoplasm.